Friday, June 10, 2016
3:30 pm – 4:25 pm
FR1: Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) Capt. Matthew Jacks, DC USN
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is one of the major complications caused by prolonged bisphosphonate administration. In this session, Dr. Jacks will present an overview of BRONJ and its treatment.
FR2: Zika and Other Infectious Diseases Edward Lifshitz, MD
While the Ebola epidemic may be a memory, a new threat has emerged to take its place, the Zika virus. Attend this session to get an update on how this virus and other infectious diseases threaten you and your patients and what you can do about it.
4:30 pm – 5:25 pm
FR3: Updated CDC Guidelines on the Management of Sexually Transmitted Infections and other Medical Updates for 2016 Everett Schlam, MD
The CDC updated its guidelines on the management of sexually transmitted infections in June 2015. Major revisions include a lower threshold for the diagnosis of urethritis based on microscopy of a urethral specimen, a new emphasis on the role of Mycoplasma genitalium in persistent urethritis and cervicitis, and other updates. This session will review the updated CDC guidelines for STIs as well as other medical updates for 2016.
FR4: Overcoming Barriers to Adult Immunizations Panel Discussion
Sometimes the biggest obstacle to improving immunization rates is the reluctance of the patient to receiving them. This session will feature a panel of physicians who have overcome this barrier and will share their secrets to success.
5:30 pm - 6:25 pm
FR5 – E Trends in Telemedicine: Exploring the Barriers and Opportunities for Family Physicians Joe Kim, MD, MPH
Telemedicine can improve patient access to care, increase efficiencies in care coordination, and ultimately improve care quality and clinical outcomes. This session will cover some of the evolving trends around the use of various types of telecommunications technology to deliver remote clinical services. Family physicians have opportunities to engage in the formal use of telemedicine, but they must also be cognizant of the latest rules and regulations around licensure requirements, reimbursement, liability risk, and more.
Satuday June 11 , 2016
8:00 am – 8:55 am
SA1: Managing T2DM in Special Populations Everett Schlam, MD
In this informative session, Dr. Schlam will discuss how to integrate emerging antihyperglycemic agents into culturally- competent, patient-centered treatment for the management of type 2 diabetes.
SA2: Identifying and Addressing Addiction vs. Dependence in Medical Practices: How DO I Wean Patients Off of Opioids and Benzodiazepines? Joseph Ranieri, DO
The decision of discontinuation of opioids and /or sedative hypnotics is very challenging. Knowing when to refer a patient for inpatient withdrawal management or considering inpatient residential vs. outpatient care, proper tapering of the drug is paramount for success and patient safety. This presentation will review strategies on safely weaning patients off opioids and sedative hypnotics.
9:00 am - 9:25 am
FF1: Over Screening in Women’s Health Ryan Kauffman, MD
The recommendations for screening of breast and cervical cancer have changed, creating a challenge for both the patient and physician. Dr. Kauffman will provide tips on how to start a conversation with your patients around screening guidelines.
FF2: ABFM’s MC-FP (MOC) – Recent Changes: What You Need to Know Now Joe Tollison, MD
Dr. Tollison will discuss the latest changes to the maintenance of certification and how they will affect you.
9:25 am - 10:00 am - Break on the Exhibit Floor
10:00 am – 10:55 am
SA3: PCSK9 Antibodies and their Impact of Cardiovascular Risk Reduction Seth Martin, MD
Monoclonal antibodies that inhibit proprotein convertase subtilisin kexin 9 (PCSK9-abs) reduce LDL-cholesterol levels. Randomized trials have shown PCSK9 inhibitors substantially reduce cardiovascular events and mortality when used for secondary prevention, both as monotherapy and in combination with statin therapy.
SA4: Understanding and Implementing POLST for End-of-Life Planning Huda Sayed, MD
POLST - Physician Orders for Life Sustaining Treatment - is an approach to end-of-life planning based on conversations between patients, loved ones, and health care professionals. POLST is designed to ensure that seriously ill or frail patients can choose the treatments they want or do not want, and that their wishes are documented and honored. Participants will learn about the POLST form and process for implementation.
11:00 am - 12:00 pm
SA5: Understanding Payment Reform Models - MACRA, APM, MIPS Michael Munger, MD (AAFP)
Payment models and the debate around them continue to be in the forefront of physicians minds. Plan to join AAFP Director Michael Munger, MD as he discusses these important issues and the AAFP response.
12:00 pm – 2:00 pm - Lunch on the Exhibit Floor
2:00 pm – 2:55 pm
SA6: The Many Facets of Chronic Pain Ken Faistl, MD
Chronic pain affects more Americans than cancer, diabetes, and heart disease combined, yet the nature of pain is poorly understood, poorly treated, and poorly discussed in primary care practice. This leads to frustration on the part of the physician and the patient, as well as sub-optimal outcomes in patient care in the treatment of chronic pain. This session will explore the role of the patient and the physician in the management of pain.
SA7: ADHD in Adults James Snyder, MD
Attention-deficit/hyperactivity disorder (ADHD) is a common neuropsychiatric disorder in adults in the United States, with a prevalence rate of 4.4%, making it second only to major depression. This session will discuss recognition and management of this condition.
3:00 pm - 4:00 pm
SA8: Concussion 2016 - Update on Diagnosis and Treatment: How Did We Get Here? Where Are We Going? Jeff Zlotnick, MD
The CDC estimates that approximately 300,000 sports concussions occur yearly in the US. Recommendations for practitioners have changed. The diagnostic criteria and expert opinion about treatment and return to physical activity have changed. Several medical organizations now recommend a more individualized approach to evaluation and management of sports concussions. Dr. Zlotnick will present the latest developments in sports related concussions.
SA9: The Impact of E-Cigarettes and Hookahs on Health Sarah Mullins, MD
After adjusting for other risk factors for smoking, baseline e-cigarette use was associated with a greater likelihood of use of any combustible tobacco product, including conventional cigarettes, cigars, and hookahs. This session will address the latest research on e-cigarettes and smoking cessation strategies.
4:00 pm - 5:25 pm
SA 10: Advancements in the Treatment of Alzheimer’s disease Helen Fernandez, MD
This session will analyze clinical advances in the treatment of Alzheimer’s disease, including the role of pharmacological and nonpharmacological options within personalized treatment plans.
SA11: Medical Management of Obesity Mark Johnson, MD
Along with diet, exercise, and behavior modification, drug therapy may be helpful for select overweight/obese adults. GLP-1 receptor agonists can promote weight loss in patients with diabetes, as well as those without diabetes. Come and learn about the latest in the medical management of obesity.
Sunday June 12, 2016
8:30 am – 9:25 am
SU1: Recognition of Diarrhea-Predominant Irritable Bowel Syndrome: Advancing Accurate Diagnosis and Appropriate Treatment Olga C. Aroniadis, MD
Irritable bowel syndrome (IBS) is a gastrointestinal syndrome characterized by chronic abdominal pain and altered bowel habits in the absence of any organic cause. It is the diagnosed gastrointestinal condition. The prevalence of IBS in North America estimated from population-based studies is approximately 10 to 15 percent. This case-based session will help you better care for your patients with IBS.
9:30 am - 10:25 am
SU2: Assessing atherosclerotic risk for long term preventive treatment Donald Smith, MD
Improved risk factor modification can decrease CVD mortality. In a nationally representative survey, five modifiable risk factors for CVD (elevated cholesterol, diabetes, hypertension, obesity, and smoking) accounted for one-half of CVD deaths in US adults aged 45 to 79. This session will present the latest research in atherosclerotic risk assessment
10:30am – 11:00am Break
11:00am – 11:55 am
SU3: Managing Direct Oral Anticoagulants John Harpel, MD
Direct Oral Anticoagulants (DOAc) are used without routine laboratory monitoring which is considered a major advantage. However, DOACs have short half-lives, and one or two missed doses can be sufficient to eliminate their anticoagulant effect.
12:00 pm – 12:55 pm
SU4: Chronic Stress and Physician Burnout Corey Martin, MD
Not all stress is bad. However, with chronic stress, the same chemicals that are life-saving in short bursts can suppress functions that are not needed for immediate survival - immunity is lowered and digestive, excretory, and reproductive systems stop working normally. Problems occur if the stress response goes on too long.
Sunday Procedure Workshops (separate fee – limited space)
8:30 am - 10:30 am
SYS1: Sharpen Your Skill Workshop 1 (Separate Registration Required)
Contraceptive Procedure Workshop Jeff Levine, MD, MPH
This session will provide practical hands-on experience in contraceptive procedures.
Attendance is limited to 30 attendees.
11:00 am - 1:00 pm
SYS2 - Sharpen Your Skills-Workshop 2 (Separate Registration Required)
Quality Improvement 101 Neil Goldfarb
This interactive, hands-on session provides an overview of quality improvement methods for the family medicine setting. The session is intended for family physicians and their staff who have limited or no familiarity with methods that can be employed to measure and improve performance in their practice. Learn how to implement a PDSA (plan-do-study-act) cycle for improving practice and how to leverage EHRs to support improvement. Need help to get started on QI measures – this is the workshop for you.
Attendance is limited to 30 attendees.
SAM Study Hall
1:15 pm - 6:00 pm: SAM Study Hall: Hypertension (Separate Registration Required) Ryan Kauffman, MD
Answers to the sixty-question knowledge assessment (Part A) during this study group will automatically be sent to the ABFM on your behalf. Participants will work together to successfully pass the knowledge assessment. You are guaranteed a passing grade for Part A as a participant in this study group. Bring your computer and you will be able to complete the clinical simulation with your peers.
Following completion of the clinical simulation portion of the module (Part B), you can claim up to 12 Prescribed CME credits.
This session requires a separate registration. The fee covers all instruction, materials, breaks and lunch.